Showing results (51-60 of 352) with videos related to
Sort By:
Pageof 36
Journal of Medical Economics|April 30, 2014
A cost-analysis model for anticoagulant treatment in the hospital settingSamir H Mody, Lynn Huynh, Daisy Y Zhuo, et al.Advances in Therapy|March 22, 2023
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial FibrillationMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.Current Medical Research and Opinion|July 18, 2023
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stayCharmi Patel, Dominic Pilon, Laura Morrison, et al.Drugs - Real World Outcomes|June 8, 2023
A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with SchizophreniaDee Lin, Dominic Pilon, Laura Morrison, et al.Journal of Managed Care & Specialty Pharmacy|November 10, 2022
Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitateLaura Morrison, Dee Lin, Carmela Benson, et al.Reproductive Health|August 24, 2016
Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured populationAmy Law, Dominic Pilon, Richard Lynen, et al.Journal of Affective Disorders|May 26, 2019
Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?Dominic Pilon, John J Sheehan, Holly Szukis, et al.Journal of Medical Economics|September 13, 2014
Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare costNeeta Tandon, Luis A Balart, François Laliberté, et al.Current Medical Research and Opinion|July 26, 2017
Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world settingKruti Joshi, Marie-Hélène Lafeuille, Brianne Brown, et al.Clinical Therapeutics|September 19, 2017
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical AntipsychoticsDominic Pilon, Neeta Tandon, Marie-Hélène Lafeuille, et al.Pageof 36